Table:
begin	end	state
1	31	cytoplasmic
32	56	transmembrane
57	207	non-cytoplasmic
208	232	transmembrane
233	242	cytoplasmic
243	266	transmembrane
267	294	non-cytoplasmic
295	315	transmembrane
316	348	cytoplasmic
349	371	transmembrane
372	390	non-cytoplasmic
391	414	transmembrane
415	425	cytoplasmic

Input:
>BPHYT_RS34090 FitnessBrowser__BFirm:BPHYT_RS34090
MTTITIAADSTPESSGRLKRELKAAEARKRAMALLLIAPLAIFLLLIFVVPIGALLTRAA
QNPEVVNALPHTVASLSAWDRKTPPPDTAYTALAVDLAAIADSDGMGALARRLNVEIPGY
RSLVAKSARAMPFVDDNSKPLQLTPAQMHAKFAELDERWNDIAYWQAIAKNAGAYSPFYL
LASLDHKQDAFGHIIPTDPDQQIYLAVFSRTFVIGAAVTFFALLLGYPLAYWISTLSERR
ANLVMILVLIPFWTSILVRVAAWIVILQSEGLVNKALIGSGLLHDPLALLFNRTGVYISM
THILLPFMILPLYSVMKSIPPTYQRAAISLGSHPFAAFWRVYVPQTYPGIGAGALLVFIL
AIGYYITPALLGGPNDQMVSYYVAYFTNVTINWGMACALGGLLLAATLVLYVIYGRFTRS
SLSLG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server